Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:02 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 86.39 USD | +1.38% |
|
-0.96% | +1.34% |
| Market Cap | 49.8B 44.58B 41.56B 37.69B 71.09B 4,760B 71.54B 499B 195B 2,456B 187B 183B 7,905B | P/E 2026 * |
34.7x | P/E 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise Value | 46.16B 41.33B 38.53B 34.94B 65.91B 4,413B 66.32B 463B 181B 2,277B 173B 170B 7,328B | EV / Sales 2026 * |
6.83x | EV / Sales 2027 * | 6x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.38% | ||
| 1 week | -0.96% | ||
| Current month | +0.08% | ||
| 1 month | +2.39% | ||
| 3 months | -6.31% | ||
| 6 months | +10.94% | ||
| Current year | +1.34% |
| 1 week | 82.42 |  | 87.3 |
| 1 month | 82.42 | | 89.7 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.4 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.38% | -0.96% | +16.84% | +23.56% | 49.12B | |
| +0.64% | -2.15% | +26.19% | +37.23% | 243B | |
| +0.63% | -0.00% | +9.26% | +5.59% | 155B | |
| +0.87% | +5.21% | -0.45% | +60.69% | 150B | |
| +2.60% | +3.40% | -54.05% | -9.87% | 61.93B | |
| +1.25% | +5.82% | -16.06% | -17.42% | 48.78B | |
| +0.46% | +0.02% | +25.41% | +57.27% | 48.08B | |
| -0.09% | +4.37% | +3.23% | +36.99% | 47.95B | |
| -0.38% | -1.82% | +30.54% | +72.15% | 42.62B | |
| -0.54% | -5.80% | +194.77% | +112.17% | 42B | |
| Average | +0.68% | +2.92% | +23.57% | +37.84% | 88.81B | |
| Weighted average by Cap. | +0.73% | +2.65% | +17.22% | +34.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.05B 5.64B 5.12B 9.65B 646B 9.72B 67.82B 26.55B 334B 25.4B 24.84B 1,074B | 7.43B 6.65B 6.2B 5.63B 10.61B 711B 10.68B 74.55B 29.18B 367B 27.92B 27.3B 1,180B |
| Net income | 1.44B 1.28B 1.2B 1.09B 2.05B 137B 2.06B 14.39B 5.63B 70.8B 5.39B 5.27B 228B | 1.9B 1.7B 1.58B 1.44B 2.71B 181B 2.73B 19.03B 7.45B 93.61B 7.13B 6.97B 301B |
| Net Debt | -3.63B -3.25B -3.03B -2.75B -5.18B -347B -5.22B -36.41B -14.25B -179B -13.64B -13.34B -576B | -5.19B -4.65B -4.34B -3.93B -7.42B -497B -7.46B -52.1B -20.39B -256B -19.51B -19.08B -825B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | US$86.39 | +1.38% | 3,324,330 |
| 26-10-09 | US$85.21 | +1.15% | 3,890,502 |
| 26-10-08 | US$84.24 | -1.80% | 6,522,221 |
| 26-10-07 | US$85.78 | -0.81% | 3,508,088 |
| 26-10-06 | US$86.48 | -0.86% | 3,383,228 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
